Merck Serono Appoints Luciano Rossetti as Global Head of R&D
Merck Serono, the biopharmaceutical division of Merck, announced the appointment of Luciano Rossetti, M.D., as Executive Vice President and Global Head of Research & Development as of July 21, 2014.
Luciano Rossetti
In his most recent role Rossetti (57) acted as Senior Vice President Late Stage Development at Merck Sharp & Dohme, or MSD. In this position, he was responsible for the entire clinical development from Phase II to Phase V across all therapeutic areas. At MSD, he played a key role in shaping and implementing the development strategy of several potential breakthrough compounds such as Anti PD-1. He also restructured the clinical genetics group to better leverage the collaboration between discovery and clinical development. Before joining MSD in 2006, Rossetti was an internationally recognized academic scientist for 18 years.
Rossetti will be based in Billerica, outside Boston, Massachusetts (U.S.), and share his time between Merck’s headquarters in Darmstadt (Germany) and Billerica – one of Merck Serono’s four global R&D hubs.
Other news from the department people
